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SUMMARY
The interrelationship between oestrogens, endogenous
and exogenous, their effects on plasma calcium, phos-
phorus and alkaline phosphatase metabolism, and the
pathogenesis of osteoporosis are reviewed. Aspects of
research conducted by me at Groote Schuur Hospital,
Cape Town are incorporated in the discussion. The current
role of oestrogen therapy in the prevention of osteoporosis
,is presented. It is concluded that appropriate or specific
, oestrogens are of value in the prevention of osteoporosis
, but have little or no role to play once the process is fully
developed. Finally, a plea is made for conservatism with
, ovaries during gynaecological operations on young females.
S. Afr. Med. J., 45, 879 (1971).
Postmenopausal osteoporosis has been the subject of
several reviews'" and the present discussion is limited to
defining the problem in terms of the relationship between
oestrogen deficiency or oestrogen therapy, calcium and
phosphorus metabolism and osteoporosis. The decreasing
ovarian function of the climacteric is said to be a factor
leading to the development of osteoporosis. The purpose of
this article is to clarify these relationships. Aspects of re-
search conducted at a Menopause Clinic, Groote Schuur
Hospital, will be incorporated in the discussion.' Finally,
some conclusions as to the current role of oestrogen
therapy in the prevention of osteoporosis in postmeno-
pausal or prematurely castrated females will be presented.
OSTEOPOROSIS-OBSCURE PATHOGENESIS
It was not until 1941 that Albright et al." described Qsteo-
porosis as a clinical entity. Osteoporosis is a common
clinical disorder which may cause backache or fracture in
the elderly. It is characterized by a reduced amount of
bony tissue per unit volume of bone in the affected part
or parts of the skeleton. Unlike osteomalacia, there are no
known specific biochemical abnormalities in osteoporosis
and most authors agree that osteoporotic bone, while re-
duced in quantity, is essentially normal in chemical com-
position.'
The investigation of osteoporosis has been handicapped
by the lack of satisfactory objective radiodiagnostic criteria.
The Medical Research Council's Mineral Metabolism
Unit has developed 2 quantitative measures." 'The first
method is X-ray densitometry and the second isotope den-
sitometry. Lanzl and Strandjord' have also reported on a
radio-isotopic device for measuring bone mineral. Un-
fortunately none of these techniques can give direct
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measurements; in this respect bone biopsy alone is the
method of choice.
The pathogenesis of osteoporosis is obscure. The osteo-
porotic process commences or accelerates in women soon
after the natural or induced menopause.",7,1O.'O For this
reason Albright et al."u attributed the condition to gonadal
insufficiency resulting in a reduced rate of synthesis of bone
collagen (matrix). This theory has not been substantiated
by most isotope kinetic studies,.,15 and tends to be refuted
by histological evidence suggesting bone resorption and
normal bone formation.'" This recent work, (reviewed by
Nordin et al.)" demonstrating increased bone resorption
possibly related to calcium deficiency" rather than de-
creased bone formation as the likely cause of osteoporosis,
has cast doubt not only on the collagen theory but also on
the role of the gonadal hormones.'s Although doubt has
been accentuated by the absence of convincing evidence
that osteoporosis responds to treatment with gonadal
hormones, it does appear that osteoporosis is related to
endogenous oestrogen deficiency.' However, the evidence
is circumstantial and not all workers are in agreement."'"
It seems that, although the osteoporosis of postmeno-
pausal women may ultimately be due to hormonal de-
ficiency, its immediate cause must lie in the regulation of
calcium absorption or excretion.7,3l."
OESTROGENS AND CALCIUM METABOLISM
Factors as described above have focused attention on the
menopause and therefore on the effects of the .oestrogenic
hormones on calcium metabolism. lasani et. al." considered
that careful measurement of plasma calcium might be one
way of distinguishing whether the negative calcium balance
of osteoporosis is secondary to a primary rise in bone re-.
sorption, or whether the rise in bone resorption is the'
result of an external negative calcium balance. They
theorized that 'if the loss of oestrogenic activity has a
direct effect upon bone resorption and increases the release
of calcium into the plasma, it will tend to raise the serum
calcium and so also the urinary calcium. If, on the other.
hand, oestrogens tend to increase either the renal tubular
reabsorption of calcium or the absorption of calcium from
the small intestine (or both) then deficiency of oestrogenic
hormones (unless associated with an increased calcium'
intake) would tend to lower the plasma calcium and
consequently increase the rate of bone resorption in order
to maintain the plasma level. Thus the difference between
these two processes is in their effect on plasma calcium
(see Fig. 1).
'According to one hypothesis, oestrogens would tend to .
lower urinary calcium thereby raisin,g the plasma level and
reducing bone resorption; according to the other, oestro-
gens would tend to lower plasma calcium and so lower
urinary calcium and improve calcium balance'.
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Raised Plasma Calcium
Although the above biochemical changes can be re-
versed by oestrogenic hormones," there is scant evidence of
improvement of osteoporosis following such therapy.
Lafferty et al.'8 found that oestrogens primarily reduce bone
resorption and do not stimulate bone formation. In fact,
after prolonged administration a secondary decline in bone
formation occurred. Thus, despite publications""2S,.. sug-
gesting prophylactic oestrogen therapy and reports on relief
of symptoms, there is little evidence of increased bone
formation by densitometry, X-ray or histological
studies."18,,0,,,
GROOTE SCHUUR STUDY
This study was planned to incorporate an investigation into
plasma calcium, phosphorus and alkaline phosphatase
levels. Thus there was no attempt to demonstrate the
development of frank osteoporosis; rather an attempt was
made to prove one step in the pathogenesis of the disease.
The purpose was to compare oophorectomized to non-
oophorectomized patients and then to study further the
effect of various exogenous oestrogens on the above para-
meters.'
Plasma alkaline phosphatase levels were performed for
the sake of completeness. There are two important causes
for raised serum alkaline phosphatase activity: those
diseases of bone in which there is increased osteoblastic
activity; and the diseases of the liver, especially where
there is obstruction to the outflow of bile.'" These levels,
therefore, have an established place in the investigation of
suspected diseases of bone.
It is not the purpose of this article to present the detailed
results, which are reported elsewhere,' but to summarize
the more important and pertinent findings and define the
place of such effects with regard to prevention and treat-
ment of osteoporosis.
The principal aims of the study required a detailed
clinical history and examination and the collection of
material from varying groups of women whose samples
would reflect an average physiological status for the group
in question, The acquisition of this comprehensive material
from sufficient patients and on repeated occasions over a
period of 1 year for each patient posed a difficult organi-
zational problem. Accordingly, a special Menopause Clinic
was established in the Outpatient Department of Groote
Schuur Hospital. This was conducted at a regular time
each week for 2 years. The study comprised inpatients
gathered for follow-up and outpatients who were recalled
following a survey of the records of the Department of
Gynaecology.
Patients were selected according to strict criteria. The
only variable features related to the state of the ovaries
and uterus. These groups included normal premenopausal
females and patients who had undergone hysterectomy
with and without bilateral oophorectomy.
Plasma calcium, inorganic phosphorus and alkaline
phosphatase values were determined for patients in the
above groups and then statistically compared. A group of
50 oophorectomized female volunteers were further ob-
served for a period of I year, during which time control
observations preceded single-blind cross-over administra-
tion of 2 forms of oestrogen and a placebo. The post-
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Their preliminary results suggested that oestrogens do
not raise the plasma calcium and that the menopause
(oestrogen deficiency) is associated with a slight rise in
plasma and urinary calcium. They therefore suggested that
oestrogenic hormones have an action on the blood/bone
equilibrium antagonistic to that of parathyroid hormone
Decreased Plasma Calcium
Fig. 1. Diagram of theoretical effect of oestrogen on
plasma calcium.
and that a reduction of oestrogenic activity leads to a
marginal elevation of plasma calcium and so to hyper-
calciuria and to negative calcium balance. They have sug-
gested, moreover, that parathyroid hormone can break
down bone more easily when oestrogens are not present
The degree of osteoporosis which this produces must
depend upon the length of time which elapses before the
subject re-adapts to the new situation.
A further report" showed a significant rise in plasma
and urinary calcium and phosphorus values after the
menopause_ In the premenopausal women, fasting plasma
calcium was 9-32 mg/lOO ml and phosphorus 3·31 mg/lOO
ml. After the natural menopause the corresponding values
were 9-62 and 3·52_ After the artificial menopause the cor-
responding values were 9·81 and 3·62. The rise of plasma
and urinary calcium was most apparent during the first
years after the cessation of menstrual periods_ They inter-
preted these changes to mean that the menopause is fol-
lowed by a rise in bone resorption which leads to a rise in
plasma and urinary calcium and phosphorus. Szymendera
and Madajewicz" have reported similar findings.
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GENERAL DISCUSSION
TABLE I. TREATMENT SCHEDULE FOR OOPHORECTOMY
GROUP
oophorectomy groups were selected for detailed study
because the climacteric cannot be accurately timed. Hence
it is virtually impossible to collect a study group of human
material at an accurately timed menopause other than in
this way. Treatment was prescribed or changed according
to Table I.
Young and Nordin'" demonstrated a significant rise in
plasma and urinary calcium and phosphorus values after
the menopause. In their premenopausal women, plasma
calcium was 9·32 mg/lOO ml and phosphorus 3·31 mg/
100 ml (9·68 and 3-63 in the present study). After the
artificial menopause the corresponding values were 9·81
and 3·62 mg/lOO ml (9-68 and 3·63 in the present study).
They found the rise of plasma and urinary calcium to be
most apparent during the first years after the cessation of
the menstrual periods. These findings were confirmed by
Szymendera and Madajewicz." Young and Nordin'" inter-
preted these changes to mean that the menopause is
followed by a rise in bone resorption which leads to a rise
in plasma and urinary phosphorus. The phosphorus values
of the Groote Schuur investigation' were similar and this
interpretation is acceptable. The failure of the Groote
Schuur investigation to confirm the changes in plasma
calcium with menopause is inexplicable, especially in view
of the fact that the methods of measurement were similar
in both instances (Autoanalyzer) and the effect of oestrogen
on plasma calcium was so dramatic in the present study.
The present investigation in fact demonstrated exogenous
oestrogen therapy to be extremely effective in reducing
plasma calcium and inorganic phosphorus values in
oophorectomized females. These findings confirm those of
Jasani et al.," who found that a significant fall of plasma
calcium could be demonstrated following oestrogen ad-
ministration, provided the plasma calcium was measured
by Autoanalyzer and not by flame-photometry. They sug-
gested, as a result of their study, that oestrogenic hormones
have an action on the blood/bone equilibrium antagonistic
to the parathyroid hormone. The fall in plasma calcium
and inorganic phosphorus has been shown to be due pri-
marily to reduced bone resorptionYs Referring back to
Fig. 1 it now becomes obvious which mechanism for
oestrogen control of plasma calcium is in fact operative.
Jasani et al." calculated that, since the sites of bone loss
appear to be highly selective,' a negative calcium balance
of only 50 mg daily for 5 years (15 - 20 g calcium) would
be sufficient to destroy a significant amount of trabecular
bone.
Taking into account the findings and discussion above,
the conclusion of the present investigation is that exo-
genous oestrogen therapy tends to lower plasma calcium
and inorganic phosphorus, presumably by inhibiting bone
resorption. Such therapy is therefore of potential value in
the prevention of oesteoporosis and is indicated, at least,
in the premenopausal female who undergoes the operation
of bilateral oophorectomy. These findings in relation to
bone metabolism could be used as a reason for prescribing
oestrogens prophylactically to all women for life from the
menopause onwards.
An interesting observation of the present investigation'
was the disparity in effect of the two forms of oestrogen
administered_ Conjugated equine oestrogen was extremely
effective in reducing the plasma calcium levels whereas
oestradiol valerate was statistically ineffective. Both oestro-
gens were effective in reducing plasma inorganic phos-
phorus, the conjugated oestrogens being slightly more
effective. There are no satisfactory comparative trials in
the literature. However, Young et al." have shown that
administration of ethinyl-oestradiol to postmenopausal
women was associated with a small but significant fall in
plasma calcium and phosphorus. Wallach and Henneman'"
suggested that diethylstilboestrol and conjugated equine
oestrogens were prophylactic against postmenopausal
osteoporosis, their observations being clinical and radio-
logical. Hernberg" found a negligible reduction in height
during ethinyl-oestradiol and hexoestrol treatment in com-
parison to control cases of the same age group. Neither
Hernberg" nor Wallach and Henneman'" included calcium




































The results, in summary, were as follows: Comparison
between normal premenopausal patients and groups fol-
lowing hysterectomy with and without ovarian conserva-
tion showed no difference in the range of values of plasma
calcium. Nevertheless, administration of conjugated equine
oestrogen resulted in a significant lowering of the mean
plasma calcium values cP<O·0025). In this effect con-
jugated oestrogen was also shown to be statistically
superior to oestradiol valerate.
The plasma inorganic phosphorus values were more
difficult to interpret. Although the findings suggest that
- the ovary is effective in either causing a reduction in or
preventing an elevation of plasma inorganic phosphorus,
it is impossible to place any strict interpretation on the
results. Nevertheless, exogenous oestrogen replacement
therapy was shown to be effective in reducing plasma
inorganic phosphorus, and this property was common to
both forms of oestrogen used.
The average values for alkaline phosphatase in all the
groups investigated were well within the range of normality.
This is supportive evidence that no patients admitted to
the investigation were suffering any manifest forms of
bone disease.
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tiate between the specific types of oestrogen used. In both
instances all cases treated were a.nalysed together as a
single group. The present investigation is therefore con-
sidered of importance in indicating that certain oestrogens
are more likely to be effective than others in the future
management of oesteoporosis and a strict evaluation of
all available oestrogenic substances is considered to be a
subject for further research.
CONCLUSIONS
Exogenous oestrogen therapy tends to lower plasma cal-
• ium and inorganic phosphorus, presumably by inhibiting
bone resorption. Such therapy is therefore of potential
value in the prevention of osteoporosis and is indicated, at
least, in the premenopausal female who undergoes the
operation of bilateral oophorectomy. By similar argument
it would appear in this instance that there is some cause
for administration of appropriate oestrogens to all women
from the menopause onwards.
It is stressed, however, that the possible mode of action
of such oestrogen therapy is that of inhibition of bone
resorption. Once frank osteoporosis has developed, it is
extremely unlikely that exogeneous oestrogen replacement
therapy has any role to play in the treatment. Thus exo-
genous oestrogens are of potential value in the prevention,
but not the treatment of osteoporosis.
The discussion and findings presented are further" argu-
ments in favour of conservatism with ovaries during
gynaecological operations on young females.
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Book Reviews •• Boekbesprekings
HENRY GLUCKMAN'S SPEECHES
A biding Vallles. Speeches and addresses by Doctor the
Honourable Henry Gluckman, M.R.C.S. (Eng), L.R.C.P.
(Lond.), LL.D. (Hon Causa, Rhodes). Pp. 522. Illustrated.
R6.50. Johannesburg: Caxton. 1970.
This is a compilation of the speeches and addresses of a former
Minister of Health in the Smuts government, covering periods
before, during and after Dr Gluckman's administration of the
Health Portfolio. These addresses have been edited and some
condensed with a conscientious avoidance of controversial is-
sues. The result is a fairly objective picture of some recent
South African social history and many of Dr Gluckman's
acitivities in the service of the community.
This work is really in the nature of a scrapbook with numer-
ous illustrations, many of rather superficial interest and some
entirely devoid of interest. As for the speeches, I very much
doubt whether the medical fraternity, at any rate, will find
in them any measure of intellectual nourishment whatsoever.
A socio-political record of a kind is about all one can call this
book, which is not likely to appeal to many readers.
E.M.S.
ANAESTHESIOLOGY
Progress in Anaesthesiology. Proceedings of the 4th World
Congress of Anaesthesiologists, London, 1968. Ed. by T. B.
Boulton, R. Bryce-Smith, M. K. Sykes, G. B. Gillett, and
A. L. Revel!. Pp. xxx + I 302. Illustrated. £31.40. Amster-
dam: Excerpta Medica. 1970.
This monumental, well-illustrated volume records all the
activities of the 4th World Congress of Anaesthesiologists.
The texts of over 300 papers are presented in symposia and
~ree-p~per sessions by well-accredited world authorities, deal-
mg 'wIth every aspect and problem of modem anaesthesia.
The IJri'ce will preclude .that this book find a place in private
libranes, .but every medIcal school should possess this unique
presentatIOn for easy reference by its students.
J.F.D.
d
